Orphan drugs , drugs intended to prevent, diagnose or treat rare diseases/disorders, are huge sellers for the pharmaceutical industry. NPR, citing data from EvaluatePharma, noted that seven of the 10 best-selling ...
- Market Realist•yesterday
After closing last week almost unchanged, the health care sector started the week on a weaker note. On Tuesday, the S&P 500 Health Care sector fell 0.45%.
- Motley Fool•2 days ago
Celgene's high-priced medicine has helped the drugmaker deliver investors significant growth, but growing pushback on pricing by Donald Trump this year could make the company's shares riskier than they've been in that past.
CG3.BE: Summary for CELGENE CORP. DL-,01 - Yahoo Finance
CELGENE CORP. DL-,01 (CG3.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 8:08AM CET
People also watch
|Bid||108.26 x 11000|
|Ask||108.54 x 10900|
|Day's range||113.16 - 113.16|
|52-week range||87.60 - 116.80|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|